Suppr超能文献

俄勒冈州医疗贫困计划的终结:失去处方药覆盖范围的影响。

The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.

作者信息

Zerzan Judy, Edlund Tina, Krois Lisa, Smith Jeanene

机构信息

Seattle VA Health Services Research and Development, 1100 Olive Way, #1400, Seattle, WA 98101, USA.

出版信息

J Gen Intern Med. 2007 Jun;22(6):847-51. doi: 10.1007/s11606-007-0178-4. Epub 2007 Mar 23.

Abstract

BACKGROUND

In January 2003, people covered by Oregon's Medically Needy program lost benefits owing to state budget shortfalls. The Medically Needy program is a federally matched optional Medicaid program. In Oregon, this program mainly provided prescription drug benefits.

OBJECTIVE

To describe the Medically Needy population and determine how benefit loss affected this population's health and prescription use.

DESIGN

A 49-question telephone survey instrument created by the research team and administered by a research contractor.

PARTICIPANTS

A random sample of 1,269 eligible enrollees in Oregon's Medically Needy Program. Response rate was 35% with 439 individuals, ages 21-91 and 64% women, completing the survey.

MEASUREMENTS

Demographics, health information, and medication use at the time of the survey obtained from the interview. Medication use during the program obtained from administrative data.

RESULTS

In the 6 months after the Medically Needy program ended, 75% had skipped or stopped medications. Sixty percent of the respondents had cut back on their food budget, 47% had borrowed money, and 49% had skipped paying other bills to pay for medications. By self-report, there was no significant difference in emergency department visits, but a significant decrease in hospitalizations comparing 6 months before and after losing the program. Two-thirds of respondents rated their current health as poor or fair.

CONCLUSIONS

The Medically Needy program provided coverage for a low-income, chronically ill population. Since its termination, enrollees have decreased prescription drug use and increased financial burden. As states make program changes and Medicare Part D evolves, effects on vulnerable populations must be considered.

摘要

背景

2003年1月,俄勒冈州医疗贫困项目的参保人员因州预算短缺而失去了福利。医疗贫困项目是一项由联邦政府配套资金的选择性医疗补助项目。在俄勒冈州,该项目主要提供处方药福利。

目的

描述医疗贫困人群,并确定福利丧失如何影响该人群的健康状况和处方药物使用情况。

设计

由研究团队创建并由研究承包商管理的一份包含49个问题的电话调查问卷。

参与者

从俄勒冈州医疗贫困项目中符合条件的参保人员中随机抽取1269人。回复率为35%,439人(年龄在21岁至91岁之间,女性占64%)完成了调查。

测量

通过访谈获取调查时的人口统计学信息、健康信息和药物使用情况。从行政数据中获取项目实施期间的药物使用情况。

结果

在医疗贫困项目结束后的6个月内,75%的人跳过或停止了用药。60%的受访者削减了食品预算,47%的人借了钱,49%的人跳过支付其他账单来支付药费。自我报告显示,急诊就诊次数没有显著差异,但与失去该项目前6个月相比,住院人数显著减少。三分之二的受访者将他们目前的健康状况评为差或一般。

结论

医疗贫困项目为低收入慢性病患者群体提供了保障。自该项目终止以来,参保人员减少了处方药的使用,增加了经济负担。随着各州对项目进行调整以及医疗保险D部分的发展,必须考虑对弱势群体的影响。

相似文献

1
The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.
J Gen Intern Med. 2007 Jun;22(6):847-51. doi: 10.1007/s11606-007-0178-4. Epub 2007 Mar 23.
2
The Effect Of Medicaid On Medication Use Among Poor Adults: Evidence From Oregon.
Health Aff (Millwood). 2017 Dec;36(12):2110-2114. doi: 10.1377/hlthaff.2017.0925.
3
Uninsurance among children whose parents are losing Medicaid coverage: Results from a statewide survey of Oregon families.
Health Serv Res. 2008 Feb;43(1 Pt 2):401-18. doi: 10.1111/j.1475-6773.2007.00764.x.
4
The Oregon experiment: the role of cost-benefit analysis in the allocation of Medicaid funds.
Soc Sci Med. 1997 Aug;45(4):545-54. doi: 10.1016/s0277-9536(96)00395-4.
6
Early Performance in Medicaid Accountable Care Organizations: A Comparison of Oregon and Colorado.
JAMA Intern Med. 2017 Apr 1;177(4):538-545. doi: 10.1001/jamainternmed.2016.9098.
8
States' control of prescription drug spending: a heterogeneous approach.
Health Aff (Millwood). 2005 Jul-Aug;24(4):1032-8. doi: 10.1377/hlthaff.24.4.1032.
9
Medicaid increases emergency-department use: evidence from Oregon's Health Insurance Experiment.
Science. 2014 Jan 17;343(6168):263-8. doi: 10.1126/science.1246183. Epub 2014 Jan 2.
10
Oregon's Medicaid ranking and cost-effectiveness: is there any relationship?
Med Decis Making. 1996 Apr-Jun;16(2):99-107. doi: 10.1177/0272989X9601600201.

本文引用的文献

2
Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):877-84. doi: 10.1002/pds.1119.
3
Medicaid cost containment and access to prescription drugs.
Health Aff (Millwood). 2005 May-Jun;24(3):780-9. doi: 10.1377/hlthaff.24.3.780.
8
Do drug benefits help Medicare beneficiaries afford prescribed drugs?
Health Aff (Millwood). 2004 Jul-Aug;23(4):213-22. doi: 10.1377/hlthaff.23.4.213.
9
Medicaid prescription drug spending in the 1990s: a decade of change.
Health Care Financ Rev. 2004 Spring;25(3):5-23.
10
Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health.
Value Health. 2004 Mar-Apr;7(2):133-43. doi: 10.1111/j.1524-4733.2004.72325.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验